Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate/Simvastatin Fixed Combination in Dyslipidemia
NCT01674712Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of fenofibrate, simvastatin in dyslipidemia, sponsored by Abbott Laboratories. Started Jun 2012; status: completed.
02
Drugs
fenofibratesimvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01674712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674712.